Healthtech Startups

American Pathology Partners (AP2) was a laboratory and pathology services company; it has sold all of its operations, including UniPath, Alliance Health Sciences, Cytology Associates, Palm Beach Pathology, and Eastern Carolina Pathology, and no longer provides laboratory or pathology services.

1 investor

The American Cancer Society is a nonprofit cancer-fighting organization that combats cancer through advocacy, research, and patient support. It provides information, resources, and services for cancer patients, families, and caregivers, and funds cancer research.

1 investor

Ameriprohealthis an emergency medical transport and response service that provides rapid patient transfers, hospital discharge coordination, and medical transport for scheduled visits.

1 investor

Ametris provides sensor-based digital measures and digital endpoints for clinical trials, capturing data from wearable sensors and real-world patient insights. Now part of Signant Health, it supports clinical trial sponsors running decentralized, hybrid, and traditional studies alongside electronic Clinical Outcome Assessment (eCOA) capabilities.

1 investor

AMGA Foundation is a nonprofit organization that brings together medical groups, health systems, and providers to address public health challenges through population health initiatives and quality improvement programs. It develops evidence-based best practices for managing chronic conditions, preventing illnesses, and improving healthcare outcomes for millions of patients across the United States.

1 investor

AMHC is a Certified Community Behavioral Health Clinic providing integrated mental health and substance use treatment services across a three-county region in Maine. Operating 27 locations with 350+ employees, the organization annually serves approximately 5,500 clients through comprehensive programs addressing mental health, addiction, crisis support, and related behavioral healthcare needs.

1 investor

AMI-Lab is a research platform that integrates physical sensors with semantic AI engines to enable ambient intelligence applications in homes, hospitals, and cities. The platform provides interconnected layers including IoT frameworks, multi-agent middleware, ontologies, and federated learning infrastructure for privacy-preserving machine learning on distributed IoT nodes.

1 investor

Amicare connects families with vetted home care providers for aging in place and personalized care needs. The platform streamlines matching between care seekers and trusted caregivers to address gaps in accessible, flexible home care services.

1 investor

Amino Analytica designs rapid molecular diagnostic tests for emerging infectious diseases and biological threats, developed in weeks rather than the traditional 12+ months. The company combines point-of-care diagnostics technology with AI-driven bionanotechnology to enable earlier detection and faster pandemic response.

1 investor

Amino Collective is an early-stage venture capital firm that invests in health and biotechnology companies at the pre-seed and seed stages. The firm operates with a concentrated investment approach, typically backing a small number of companies annually.

1 investor

AMIRA is a multichannel marketing platform and community focused on reaching pharmacy professionals including pharmacists, pharmacy technicians, and pharmacy staff in the German-speaking pharmacy market.

1 investor

AMIRO manufactures a home microneedling device that delivers serums containing PDRN and other anti-aging ingredients to address fine lines, uneven texture, and dullness. The product is designed as an at-home skincare treatment for consumers seeking clinic-level skin rejuvenation without professional appointments.

1 investor

Amnova Biotech develops injectable therapies derived from amniotic biomaterials to promote heart regeneration following ischemic injury. The company targets cardiac regenerative medicine and is advancing its lead therapies from preclinical validation toward clinical application.

1 investor

Amorphous transforms unstructured hospital data into standardized, queryable formats using AI, enabling hospitals to derive operational, financial, and clinical insights for decision-making. The platform serves hospital operations and finance teams by automating data analysis tasks that typically require manual weeks of work.

1 investor

Amotio develops a guided bone cement removal system with patient-specific surgical planning and precision instrumentation for orthopaedic revision surgery, targeting arthroplasty and revision surgeons who work with cemented joint implants. The medical device company, based in the Netherlands and Wales, is preparing for US commercial launch in the revision arthroplasty market.

1 investor

Amoy Diagnostics develops molecular diagnostic test kits for cancer detection, including PCR, IHC, FISH, and next-generation sequencing products that detect gene mutations such as PIK3CA, KRAS, NRAS, BRAF, and IDH1, as well as microsatellite instability. Its products serve clinical and oncology diagnostics and include related nucleic acid extraction reagents and instruments.

1 investor

Amperos automates and manages insurance claim recovery for healthcare providers, reducing denials and processing backlogs through a combination of automation and expert oversight. The platform helps revenue cycle teams resolve claims with improved consistency and visibility.

1 investor

Ampersand provides a digital platform for remote patient monitoring and clinician communication, enabling healthcare teams to track symptoms, deliver digital therapies, and manage patient care in outpatient settings. The platform includes messaging tools, symptom tracking, medication reminders, and expert-led educational content for patients managing chronic conditions.

1 investor

Amphastar Pharmaceuticals manufactures and distributes generic and branded pharmaceutical products, including injectable medications, inhalation aerosols, and emergency treatments for medical professionals and patients in the United States.

1 investor

1 investor

Amplicore Pharma develops an injectable pharmaceutical formulation targeting musculoskeletal disorders, particularly osteoarthritis, designed to slow cartilage degeneration and reduce symptoms as an alternative to joint replacement surgery.

1 investor

Amplifai develops an AI-powered platform (TFscan) that detects diabetic foot complications in real time to support clinical decision-making and prevent amputations. The system integrates with hospital and clinic infrastructure to provide risk scores and analytics for patient care teams.

1 investor

Amplifire provides adaptive learning software for training healthcare clinicians on Epic electronic health record systems. The platform uses personalized algorithms and analytics to reduce training time while improving EHR proficiency and satisfaction among physicians, nurses, and clinical support staff.

1 investor

Amplifyer develops liquid biopsy technology aimed at improving outcomes for cancer patients. The company operates in the biotech and diagnostics space.

1 investor